FDA announces changes to HPV vaccinations

Svjetlana Stojanovic   News staff writer  
December 8th, 2009 - 4:10 PM
December 9th, 2009 - 11:57 PM
Champaign-Urbana
Recommend thisPost a commentDecrease Text SizeIncrease Text Size

Changes to HPV vaccinations have been announced by the FDA and CDC.

According to a press release from David Lawrance, medical director at McKinley, another HPV vaccine has been approved for women alongside the first vaccine known as Gardasil. This second vaccine is Ceravix and protects against the same high-risk strains of HPV as Gardasil.

The press release stated that McKinley has not yet confirmed as to whether they will carry the vaccine.

In addition to the new vaccine, the press release stated that the FDA has approved the use of the Gardasil vaccine to fight genital warts in men ages 9-26.

According to the press release McKinley will be offering the Gardasil vaccine to men who ask for it. The vaccine is a three-shot series that is given over six months.

Post a commentRecommend this

Reader's Comments

Tired of being anonymous? Put a name to your comments! Login or register. Registered users can use avatar images and create new forum topics.

Post new comment:
All comments are published at the discretion of The Daily Illini. Comments are the opinions of the individuals leaving them and do not reflect the views of The Daily Illini, Illini Media or its affiliated and related entities, or its partners, sponsors, advertisers or content providers. Comments are intended to be a means of reaction to a specific article, podcast, or gallery and will be moderated for obscenity and hateful language. Do not submit commercial, off-topic or other copyrighted material.

The content of this field is kept private and will not be shown publicly.
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.